Skip to main content

Better late than early: FDG-PET imaging in metastatic renal cell carcinoma.

Publication ,  Journal Article
Harrison, MR; George, DJ
Published in: Clin Cancer Res
September 15, 2011

Sunitinib treatment benefits patients with metastatic renal cell carcinoma (mRCC), but response duration can vary widely and resistance is not predicted by standard measures. [¹⁸F]fluoro-2-deoxy-2-D-glucose positron emission tomography (FDG-PET) uptake is variable in mRCC, but changes in FDG-PET uptake may be useful in monitoring disease progression. Further work is needed to personalize treatment for patients with mRCC.

Duke Scholars

Published In

Clin Cancer Res

DOI

EISSN

1557-3265

Publication Date

September 15, 2011

Volume

17

Issue

18

Start / End Page

5841 / 5843

Location

United States

Related Subject Headings

  • Radiopharmaceuticals
  • Positron-Emission Tomography
  • Oncology & Carcinogenesis
  • Neoplasm Metastasis
  • Kidney Neoplasms
  • Humans
  • Fluorodeoxyglucose F18
  • Carcinoma, Renal Cell
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Harrison, M. R., & George, D. J. (2011). Better late than early: FDG-PET imaging in metastatic renal cell carcinoma. Clin Cancer Res, 17(18), 5841–5843. https://doi.org/10.1158/1078-0432.CCR-11-1768
Harrison, Michael R., and Daniel J. George. “Better late than early: FDG-PET imaging in metastatic renal cell carcinoma.Clin Cancer Res 17, no. 18 (September 15, 2011): 5841–43. https://doi.org/10.1158/1078-0432.CCR-11-1768.
Harrison MR, George DJ. Better late than early: FDG-PET imaging in metastatic renal cell carcinoma. Clin Cancer Res. 2011 Sep 15;17(18):5841–3.
Harrison, Michael R., and Daniel J. George. “Better late than early: FDG-PET imaging in metastatic renal cell carcinoma.Clin Cancer Res, vol. 17, no. 18, Sept. 2011, pp. 5841–43. Pubmed, doi:10.1158/1078-0432.CCR-11-1768.
Harrison MR, George DJ. Better late than early: FDG-PET imaging in metastatic renal cell carcinoma. Clin Cancer Res. 2011 Sep 15;17(18):5841–5843.

Published In

Clin Cancer Res

DOI

EISSN

1557-3265

Publication Date

September 15, 2011

Volume

17

Issue

18

Start / End Page

5841 / 5843

Location

United States

Related Subject Headings

  • Radiopharmaceuticals
  • Positron-Emission Tomography
  • Oncology & Carcinogenesis
  • Neoplasm Metastasis
  • Kidney Neoplasms
  • Humans
  • Fluorodeoxyglucose F18
  • Carcinoma, Renal Cell
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences